PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
19-Apr-2023 The Pharma Mini MBA Training Course: Accelerated Management Programme for Pharmaceutical Industry Employees - ResearchAndMarkets.com Businesswire
19-Apr-2023 An Introduction to the Medical Device Regulation Training Course: In-Depth Insight Into the European MDR Legislation - ResearchAndMarkets.com Businesswire
19-Apr-2023 David Herron Appointed as Calyx CEO Businesswire
19-Apr-2023 Global Hepatic Encephalopathy Therapeutics Market Report 2023: Players Include Mallinckrodt Pharmaceuticals, Salix Pharmaceuticals, GlaxoSmithKline and Pfizer - ResearchAndMarkets.com Businesswire
19-Apr-2023 Grünenthal Announces Pricing of €300 Million Bond Businesswire
19-Apr-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
19-Apr-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Infosys Limited (INFY) on Behalf of Investors Businesswire
19-Apr-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Plug Power Inc. (PLUG) on Behalf of Investors Businesswire
18-Apr-2023 Carbios 加速酶優化進程,一天可檢測數百萬種酶 Businesswire
18-Apr-2023 Carbios加速酶优化过程,一天可筛选数百万种酶 Businesswire
18-Apr-2023 MindMed Files Preliminary Proxy Statement for 2023 Annual Meeting Businesswire
18-Apr-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Spirit AeroSystems Holdings, Inc. (SPR) on Behalf of Investors Businesswire
18-Apr-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Alvotech (ALVO) on Behalf of Investors Businesswire
18-Apr-2023 Palleon Pharmaceuticals Presents Initial Phase 1 Results from the GLIMMER-01 Clinical Trial for E-602, the First Ever Glyco-Immune Checkpoint Inhibitor Businesswire
18-Apr-2023 AHF Applauds Ghana for Approving Malaria Vaccine, Urges WHO Approval after Trials Businesswire
18-Apr-2023 TME Pharma Announces Successful €2 Million Financing and the End of the Convertible Bond Program With a Lock-Up of New Shares and Lock-Up of Bond Conversions Extending Financial Runway Into December 2023 Businesswire
18-Apr-2023 More Than 150 Million Americans Now Have Insurance Coverage for Kerecis’ Medical-Fish-Skin Wound Treatment Businesswire
18-Apr-2023 Mythic Therapeutics Presents Preclinical Data on Investigational cMET-Targeting Antibody-Drug Conjugate (ADC) MYTX-011 at American Association for Cancer Research (AACR) Annual Meeting Businesswire
18-Apr-2023 Armis宣佈在醫療保健領域取得強勁的業務發展勢頭 Businesswire
18-Apr-2023 Armis宣布在医疗保健领域取得强劲的业务发展势头 Businesswire